Marpai Reports 36% Revenue Decline, Going Concern Warning, and Relies on Dilutive Financing & CEO Loans to Maintain Operations
MRAI sits 33% above its 52-week low of $0.338 on light trading volume (0.2× avg).
Summary
Marpai, Inc. faces significant financial distress, with auditors raising a going concern warning following a 36% revenue drop in 2025 and continued reliance on dilutive financing and short-term loans from its CEO to fund operations.
Key Events · Financing and Capital Events · MRAI
-
Going Concern Warning Issued
The independent registered public accounting firm included an explanatory paragraph in its audit report, stating 'substantial doubt about our ability to continue as a going concern' due to recurring operating losses, negative cash flows, and an accumulated deficit of $115.4 million.
-
Significant Revenue Decline in 2025
Total revenue decreased by 36% to $18.1 million in 2025 from $28.2 million in 2024, primarily due to a 28% customer attrition rate.
-
Reliance on Dilutive Financing
In 2025, the company raised $7.03 million through multiple private placements of common stock and warrants. This included the issuance of 6,849,425 shares and 8,400,000 warrants, contributing to a total of 24,035,610 shares outstanding by year-end 2025.
-
CEO Provides Short-Term Loans for Working Capital
In February and March 2026, CEO Damien Lamendola issued promissory notes totaling $660,000 to the company for general working capital, with repayment due by April and May 2026, respectively, highlighting immediate liquidity needs.
Analysis · MRAI · Industrial Applications And Services
Marpai, Inc.'s 2025 annual report reveals a critical financial situation, with auditors expressing substantial doubt about the company's ability to continue as a going concern. The company experienced a significant 36% year-over-year revenue decline to $18.1 million in 2025, alongside an accumulated deficit of $115.4 million and negative working capital of $15.4 million. Unrestricted cash stood at a mere $133,000 at year-end 2025, highlighting severe liquidity constraints. To address these challenges, Marpai has relied heavily on dilutive private placements of common stock and warrants, raising $7.03 million in 2025. Furthermore, the CEO provided $660,000 in short-term promissory notes in early 2026 for general working capital, underscoring the immediate need for funds. The company is also undergoing an operational restructuring, including a 10% workforce reduction, to streamline costs. While a lawsuit settlement for $10,000 cash and 400,000 restricted stock units (with potential for more) resolves a significant claim, the overall financial picture remains highly precarious, making this a high-risk investment.
At the time of this filing, MRAI was trading at $0.45 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $10.6M. The 52-week trading range was $0.34 to $1.78. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.